Ikarian Capital, LLC Enveric Biosciences, Inc. Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$8.8 - $16.2 $1.76 Million - $3.24 Million
-200,000 Reduced 47.19%
223,834 $48,000
Q1 2022

May 13, 2022
BUY
$12.5 - $52.0 $297,925 - $1.24 Million
23,834 Added 5.96%
423,834 $141,000
Q4 2021

Feb 14, 2022
BUY
$46.5 - $104.0 $18.6 Million - $41.6 Million
400,000 New
400,000 $372,000

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $1.04M
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email